Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06075810 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer

StatusRecruiting
PhasePhase 1
SponsorMBQ Pharma
Started2023-11-09
View on ClinicalTrials.gov ↗
A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in participants with advanced Breast Cancer for whom Standard of Care (SOC) has failed or has proven intolerable.

Amendment history 2 changes detected by DataLookout

2026-09-01
Primary completion pushed: 2025-10-01 → 2026-12-31
2026-09-01
Completion pushed: 2025-10-31 → 2026-12-31
Trial Details
NCT Number NCT06075810
Lead Sponsor MBQ Pharma
Collaborators: Congressionally Directed Medical Research Programs
Conditions Breast Cancer, Breast Neoplasm, Breast Cancer Stage IV
Enrollment 48 participants
Start Date 2023-11-09
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-31